[1] Dores GM,Devesa SS,Curtis RE,et al. Acute leukemia incidence and patient survival among children and adults in the United States,2001-2007[J].Blood,2012,119(1):34-43.[2] Valgardsdottir R,Capitanio C, Texido G,et al.Direct involvement of CD56 in cytokine-induced killer-mediated lysis of CD56+ hematopoietic target cells[J].Exp Hematol,2014,42(12):1013-1021.[3] Xu S,Li X,Zhang J,et al.Prognostic value of CD56 in patients with acute myeloid leukemia:a meta-analysis[J].J Cancer Res Clin Oncol,2015,141(10):1859-1870.[4] 魏姗姗,周茂华,李劲高,等.急性髓系白血病患者白血病细胞CD34和CD38抗原的表达及其临床意义[J].吉林大学学报:医学版,2015,41(2):362-367.[5] 张之南.血液病诊断及疗效标准[M].2版.北京:科学出版社,1998:168-218.[6] Raspadori D,Damiani D, Lenoci M,et al.CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis[J].Leukemia,2001,15(8):1161-1164.[7] Junca J,Garcia-Caro M,Granada I,et al.Correlation of CD11b and CD56 expression in adult acute myeloid leukemia with cytogenetic risk groups and prognosis[J].Ann Hematol,2014,93(9):1483-1489.[8] Iriyama N,Hatta Y,Takeuchi J,et al.CD56 expression is an independent prognostic factor for relapse in acute myeloid leukemia with t(8;21)[J].Leuk Res,2013,37(9):1021-1026.[9] Ono T,Takeshita A,Kishimoto Y,et al.Expression of CD56 is an unfavorable prognostic factor for acute promyelocytic leukemia with higher initial white blood cell counts[J].Cancer Sci,2014,105(1):97-104.[10] Mason KD,Juneja SK,Szer J.The immunophenotype of acute myeloid leukemia:is there a relationship with prognosis[J].Blood Rev,2006,20(2):71-82.[11] Alegretti AP,Bittar CM,Bittencourt R,et al.The expression of CD56 antigen is associated with poor prognosis in patients with acute myeloid leukemia[J].Rev Bras Hematol Hemoter,2011,33(3):202-206.[12] Djunic I, Virijevic M,Djurasinovic V,et al.Prognostic significance of CD56 antigen expression in patients with acute myeloid leukemia[J].Med Oncol,2012,29(3):2077-2082.[13] Chang H,Salma F,Yi QL,et al.Prognostic relevance of immunophenotyping in 379 patients with acute myeloid leukemia[J].Leuk Res,2004,28(1):43-48.[14] Chang H,Brandwein J,Yi QL,et al.Extramedullary infiltrates of AML are associated with CD56 expression,11q23 abnormalities and inferior clinical outcome[J].Leuk Res,2004,28(10):1007-1011.[15] Jekarl DW,Kim M,Lim J,et al.CD56 antigen expression and hemophagocytosis of leukemic cells in acute myeloid leukemia with t(16;21)(p11;q22)[J].Int J Hematol,2010,92(2):306-313.[16] Benderra Z,Faussat AM,Sayada L,et al.Breast cancer resistance protein and P-glycoprotein in 149 adult acute myeloid leukemias[J].Clin Cancer Res,2004,10(23):7896-7902.[17] Montesinos P,Rayón C,Vellenga E,et al.Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens[J].Blood,2011,117(6):1799-1805. |